Literature DB >> 33215316

Quality of Life in Infertile Women with Polycystic Ovary Syndrome: a Comparative Study.

Iuliia Naumova1,2, Camil Castelo-Branco3, Iuliia Kasterina4, Gemma Casals5.   

Abstract

To investigate the quality of life (QoL) of infertile women with polycystic ovary syndrome (PCOS) and analyze the association between the clinical/biochemical features of PCOS and the physical/psychological well-being of patients. An observational study with three independent groups women was designed including 37 infertile PCOS patients, 36 women with tubal factor infertility, and 31 women with male factor infertility referred to the Reproductive Medicine Unit of the Hospital Clinic Barcelona from December 2017 to June 2019. Clinical history, physical examination including Ferriman-Gallwey scores, and vaginal ultrasound were carried out in all patients. All subjects completed the 36-item Short Form Health Survey, and PCOS patients were asked to fill out the Polycystic Ovary Syndrome Questionnaire. The IBM SPSS 23.0 was used for the statistical analysis. Infertile women with PCOS reported significantly worse QoL scores of social functioning (p = 0.049), emotional role functioning (p = 0.041), mental health (p = 0.002), and the mental component summary (p = 0.002) compared with women with other causes of infertility. In addition, body pain (p = 0.006), general health (p < 0.001), and vitality (p = 0.002) scores were significantly lower in women with PCOS compared with those with male factor infertility. Infertile PCOS patients showed low scores in all domains of the PCOSQ. Hirsutism and weight gain were the factors most associated with impaired health-related QoL in PCOS. Infertile PCOS women presented worse QoL mainly due to psychological and emotional distress. The main predictors were clinical manifestations of hyperandrogenism and weight gain.

Entities:  

Keywords:  Hirsutism; Hyperandrogenemia; Infertility; PCOS; PCOSQ, SF-36; Quality of life

Mesh:

Substances:

Year:  2020        PMID: 33215316     DOI: 10.1007/s43032-020-00394-1

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  32 in total

Review 1.  Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies.

Authors:  Susanne M Veltman-Verhulst; Jacky Boivin; Marinus J C Eijkemans; Bart J C M Fauser
Journal:  Hum Reprod Update       Date:  2012-07-23       Impact factor: 15.610

2.  Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany.

Authors:  S Benson; S Hahn; S Tan; K Mann; O E Janssen; M Schedlowski; S Elsenbruch
Journal:  Hum Reprod       Date:  2009-02-16       Impact factor: 6.918

3.  Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome.

Authors:  Anuja Dokras; Elisabeth Stener-Victorin; Bulent O Yildiz; Rong Li; Sasha Ottey; Duru Shah; Neill Epperson; Helena Teede
Journal:  Fertil Steril       Date:  2018-05       Impact factor: 7.329

4.  Quality of life and psychological well being in polycystic ovary syndrome.

Authors:  L Barnard; D Ferriday; N Guenther; B Strauss; A H Balen; L Dye
Journal:  Hum Reprod       Date:  2007-05-30       Impact factor: 6.918

5.  Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome.

Authors:  Angelika Stapinska-Syniec; Klaudia Grabowska; Monika Szpotanska-Sikorska; Bronislawa Pietrzak
Journal:  Gynecol Endocrinol       Date:  2018-01-16       Impact factor: 2.260

6.  Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial.

Authors:  Charikleia Stefanaki; Flora Bacopoulou; Sarantis Livadas; Anna Kandaraki; Athanasios Karachalios; George P Chrousos; Evanthia Diamanti-Kandarakis
Journal:  Stress       Date:  2014-12-29       Impact factor: 3.493

7.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

Review 8.  The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis.

Authors:  Fatemeh Bazarganipour; Seyed Abdolvahab Taghavi; Ali Montazeri; Fazlollah Ahmadi; Reza Chaman; Ahmad Khosravi
Journal:  Iran J Reprod Med       Date:  2015-02

9.  Psychological investigation in patients with polycystic ovary syndrome.

Authors:  Fatemeh Bazarganipour; Saeide Ziaei; Ali Montazeri; Fatemeh Foroozanfard; Anoshirvan Kazemnejad; Soghrat Faghihzadeh
Journal:  Health Qual Life Outcomes       Date:  2013-08-16       Impact factor: 3.186

10.  Health-related quality of life in patients with polycystic ovary syndrome: validation of the German PCOSQ-G.

Authors:  B Böttcher; S Fessler; F Friedl; B Toth; M H Walter; L Wildt; D Riedl
Journal:  Arch Gynecol Obstet       Date:  2017-12-16       Impact factor: 2.344

View more
  2 in total

Review 1.  Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy.

Authors:  Qiaoli Zhang; Rongcai Ye; Yuan-Yuan Zhang; Chen-Chen Fan; Jun Wang; Shuyu Wang; Suwen Chen; Xiaowei Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

2.  Mendelian Randomization Analysis Identified Potential Genes Pleiotropically Associated with Polycystic Ovary Syndrome.

Authors:  Qian Sun; Yuan Gao; Jingyun Yang; Jiayi Lu; Wen Feng; Wen Yang
Journal:  Reprod Sci       Date:  2021-10-26       Impact factor: 2.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.